Last viewed:
LNSR
Prices are updated after-hours
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
(0.0% 1d)
(-7.9% 1m)
(22.1% 1y)
(0.0% 2d)
(2.5% 3d)
(0.9% 7d)
(-38.86%
volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 37,148,499
http://www.lensar.com
Sec
Filling
|
Patents
| 35 employees
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
treatment
add to watch list
Paper trade
email alert is off
Press-releases
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Published: 2024-03-04
(Crawled : 00:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| -30.64%
| O: 6.38%
H: 6.0%
C: -3.4%
business
lensar
year
update
results
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
Published: 2024-02-26
(Crawled : 15:30)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| -30.49%
| O: -5.12%
H: 13.37%
C: 9.44%
report
lensar
year
financial
results
LENSAR Reports Second Quarter 2023 Results and Provides Business Update
Published: 2023-08-09
(Crawled : 13:20)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| -1.21%
| O: -1.21%
H: 19.94%
C: 14.11%
business
lensar
update
results
LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
Published: 2023-08-02
(Crawled : 13:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| -0.31%
| O: -3.98%
H: 2.23%
C: -1.91%
report
lensar
financial
results
LENSAR Reports First Quarter 2023 Results and Provides Business Update
Published: 2023-05-15
(Crawled : 13:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| 28.35%
| O: -2.76%
H: 0.0%
C: -6.88%
business
lensar
update
results
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
Published: 2023-05-10
(Crawled : 13:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| 20.3%
| O: -3.69%
H: 3.07%
C: 2.68%
report
lensar
financial
results
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
Published: 2023-03-16
(Crawled : 13:20)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| 2.52%
| O: -0.31%
H: 8.83%
C: 2.52%
business
lensar
year
update
results
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
Published: 2023-03-09
(Crawled : 14:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| 1.87%
| O: -0.27%
H: 2.15%
C: 2.15%
report
lensar
year
financial
results
LENSAR to Present at Two Upcoming Investor Conferences - November 22, 2022
Published: 2022-11-22
(Crawled : 14:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| -11.17%
| O: 12.53%
H: 0.0%
C: -12.83%
lensar
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-09
(Crawled : 13:00)
- biospace.com/
LNSR
|
$3.26
2.52%
0.31%
8.3K
|
Health Technology
| -27.56%
| O: 1.33%
H: 0.22%
C: -12.72%
lensar
financial
update
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount